Drug intelligence / Profile preview

Yijunsheng

Development stage: Preclinical
Lead developer: Jinan Yijunsheng Medical Service
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Vaginal

Overview

Yijunsheng is a vaginal suppository developed by Jinan Yijunsheng Medical Service Co., LTD. It is indicated for the treatment of recurrent vaginitis, with its primary action focused on reconstructing the vaginal microecology. This typically involves restoring the balance of beneficial microorganisms, such as Lactobacillus species, to maintain a healthy vaginal environment and inhibit the growth of pathogenic bacteria and fungi.

Other names: Ejunsun

Beyond the preview

Go deeper on Yijunsheng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yijunsheng.

Explore the full profile